InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 24.23 CNY -3.31% Market Closed
Market Cap: 20.5B CNY

Relative Value

The Relative Value of one InnoCare Pharma Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 24.23 CNY, InnoCare Pharma Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

InnoCare Pharma Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
30
Median 3Y
13.2
Median 5Y
10.3
Industry
7.9
Forward
11.4
vs History
vs Industry
Median 3Y
-115.3
Median 5Y
-118.7
Industry
24
Forward
201.7
vs History
vs Industry
Median 3Y
-166.3
Median 5Y
-171.2
Industry
21.6
vs History
12
vs Industry
Median 3Y
-153.5
Median 5Y
-174.3
Industry
23.7
vs History
12
vs Industry
40
Median 3Y
1.5
Median 5Y
1.4
Industry
3.4
vs History
19
vs Industry
33
Median 3Y
-1.2
Median 5Y
-5
Industry
8.3
Forward
8.1
vs History
19
vs Industry
32
Median 3Y
-1.4
Median 5Y
-5.9
Industry
10.3
vs History
vs Industry
Median 3Y
-57.2
Median 5Y
-57.6
Industry
6.7
Forward
107.1
vs History
vs Industry
Median 3Y
-57.2
Median 5Y
-57.6
Industry
7.2
Forward
217
vs History
vs Industry
Median 3Y
-126.1
Median 5Y
-131
Industry
8.2
vs History
vs Industry
Median 3Y
-94.7
Median 5Y
-98.4
Industry
6.7
vs History
12
vs Industry
32
Median 3Y
1.9
Median 5Y
1.9
Industry
5.7

Multiples Across Competitors

Competitors Multiples
InnoCare Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
InnoCare Pharma Ltd
SSE:688428
20.5B CNY 15.5 -97.9 -44.4 -44.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 111 463.2 -162 126.7 -196 873.6 -194 627
US
Abbvie Inc
NYSE:ABBV
394.1B USD 6.6 167.8 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.6B USD 4.7 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
148.3B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111B USD 9.5 30.2 22.1 23.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 065.3 -527 -573.9 -558.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.7B USD 5.2 16.1 15.2 17.3
AU
CSL Ltd
ASX:CSL
88.5B AUD 3.8 19.6 13.1 16.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
55.1B USD 17.2 1 265.5 166.5 201.9
NL
argenx SE
XBRU:ARGX
47B EUR 15.2 35.7 61.7 63.4
P/S Multiple
Revenue Growth P/S to Growth
CN
InnoCare Pharma Ltd
SSE:688428
Average P/S: 3 101 237.4
15.5
47%
0.3
FR
Pharnext SCA
OTC:PNEXF
34 111 463.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
5%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
10%
0.9
US
E
Epizyme Inc
F:EPE
2 065.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.2
6%
0.9
AU
CSL Ltd
ASX:CSL
3.8
5%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.2
46%
0.4
NL
argenx SE
XBRU:ARGX
15.2
49%
0.3
P/E Multiple
Earnings Growth PEG
CN
InnoCare Pharma Ltd
SSE:688428
Average P/E: 197.2
Negative Multiple: -97.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 126.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
9%
1.8
AU
CSL Ltd
ASX:CSL
19.6
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 265.5
N/A N/A
NL
argenx SE
XBRU:ARGX
35.7
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
InnoCare Pharma Ltd
SSE:688428
Average EV/EBITDA: 40.6
Negative Multiple: -44.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 873.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.2
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
166.5
N/A N/A
NL
argenx SE
XBRU:ARGX
61.7
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
InnoCare Pharma Ltd
SSE:688428
Average EV/EBIT: 46.9
Negative Multiple: -44.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 627 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -558.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
13%
1.3
AU
CSL Ltd
ASX:CSL
16.4
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
201.9
N/A N/A
NL
argenx SE
XBRU:ARGX
63.4
N/A N/A